RNA-based therapeutics to treat human fungal infections

In recent decades, RNA-based therapeutics have transitioned from a near impossibility to a compelling treatment alternative for genetic disorders and infectious diseases. The mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are truly groundbreaking, and new adaptati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruch, Alexander, Kelani, Abdulrahman A., Blango, Matthew G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498853/
https://www.ncbi.nlm.nih.gov/pubmed/34635448
http://dx.doi.org/10.1016/j.tim.2021.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498853/
https://www.ncbi.nlm.nih.gov/pubmed/34635448
http://dx.doi.org/10.1016/j.tim.2021.09.007

Ejemplares similares